Evidence map›Paper›PMID 26822725›Full record

ArticleScientific reports2016

Quantitative Analysis of Global Proteome and Lysine Acetylome Reveal the Differential Impacts of VPA and SAHA on HL60 Cells.

Xiaoyu Zhu, Xin Liu, Zhongyi Cheng, Jun Zhu, Lei Xu, Fengsong Wang, Wulin Qi, Jiawei Yan, Ning Liu, Zimin Sun and 5 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Article
  3. Systems Biology for Drug Target Discovery in Acute Myeloid Leukemia.International journal of molecular sciences · 2024
    Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Secretome-Wide Analysis of Lysine Acetylation inFrontiers in microbiology · 2020
    Article
  10. Article
  11. Article
  12. Mechanism of Action for HDAC Inhibitors-Insights from Omics Approaches.International journal of molecular sciences · 2019
    Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 1 country.

Xiaoyu ZhuDepartment of Hematology, Anhui Provincial Hospital, Anhui Medical University, Hefei, 230001, China.
Xin LiuDepartment of Hematology, Anhui Provincial Hospital, Anhui Medical University, Hefei, 230001, China.
Zhongyi ChengTranslational Medcine Advanced Institute, Tongji University, No.1239, Siping Road, Shanghai, 200092, China.
Jun ZhuJingjie PTM Biolab (Hangzhou) Co. Ltd, Hangzhou 310018, China.
Lei XuDepartment of orthopaedics, Anhui Provincial Hospital, Anhui Medical University, Hefei, 230001, China.
Fengsong WangSchool of Life science, Anhui Medical University, Hefei, 230032, China.
Wulin QiJingjie PTM Biolab (Hangzhou) Co. Ltd, Hangzhou 310018, China.
Jiawei YanDepartment of Hematology, Anhui Provincial Hospital, Anhui Medical University, Hefei, 230001, China.
Ning LiuDepartment of Hematology, Anhui Provincial Hospital, Anhui Medical University, Hefei, 230001, China.
Zimin SunDepartment of Hematology, Anhui Provincial Hospital, Anhui Medical University, Hefei, 230001, China.
Huilan LiuDepartment of Hematology, Anhui Provincial Hospital, Anhui Medical University, Hefei, 230001, China.
Xiaojun PengJingjie PTM Biolab (Hangzhou) Co. Ltd, Hangzhou 310018, China.
Yingchan HaoCentral Laboratory of Medical Research Centre, Anhui Provincial Hospital, Anhui Medical University, Hefei, 230001, China.
Nan ZhengCentral Laboratory of Medical Research Centre, Anhui Provincial Hospital, Anhui Medical University, Hefei, 230001, China.
Quan WuCentral Laboratory of Medical Research Centre, Anhui Provincial Hospital, Anhui Medical University, Hefei, 230001, China.
Anhui Provincial Hospital · CNAnhui Medical University · CNNew England Biolabs (China) · CNTongji University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Valproic acid (VPA) and suberoylanilide hydroxamic acid (SAHA) are both HDAC inhibitors (HDACi). Previous studies indicated that both inhibitors show therapeutic effects on acute myeloid leukaemia (AML), while the differential impacts of the two different HDACi on AML treatment still remains elusive. In this study, using 3-plex SILAC based quantitative proteomics technique, anti-acetyllysine antibody based affinity enrichment, high resolution LC-MS/MS and intensive bioinformatic analysis, the quantitative proteome and acetylome in SAHA and VPA treated AML HL60 cells were extensively studied. In total, 5,775 proteins and 1,124 lysine acetylation sites were successfully obtained in response to VAP and SAHA treatment. It is found that VPA and SAHA treatment differently induced proteome and acetylome profiling in AML HL60 cells. This study revealed the differential impacts of VPA and SAHA on proteome/acetylome in AML cells, deepening our understanding of HDAC inhibitor mediated AML therapeutics.

Indexed as

ProteomicsAcetylationAmino Acid MotifsAmino Acid SequenceCluster AnalysisComputational BiologyHL-60 CellsHumansHydroxamic AcidsLeukemia, Myeloid, AcuteLysinePosition-Specific Scoring MatricesProtein Interaction MappingProtein Interaction MapsProteomeValproic AcidHydroxamic AcidsLysineProteomeValproic AcidVorinostat

Identifiers

PMID26822725
PMCPMC4731804
OpenAlexW2402659726

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.